This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovations of Philip LeQuesne
Introduction
Philip LeQuesne is an accomplished inventor based in Newton Centre, MA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel angiotropic steroids. His work focuses on innovative methods for treating gastrointestinal ulcers, showcasing his commitment to advancing medical science.
Latest Patents
LeQuesne holds a patent for Tetrahydro-S-21-Br, which is directed to novel angiotropic (angiogenic and angiostatic) steroids that are halogenated in the 21 position. This invention represents a breakthrough in the treatment of gastrointestinal ulcers, providing new avenues for patient care.
Career Highlights
Philip LeQuesne is affiliated with The Brigham and Women's Hospital, Inc., where he continues to engage in groundbreaking research. His work has positioned him as a key figure in the development of innovative treatments that address critical health issues.
Collaborations
LeQuesne has collaborated with notable colleagues such as Sandor Szabo and John L Neumeyer, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Philip LeQuesne's contributions to the field of medicine through his patent and research efforts highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile